A validated antibody panel for the characterization of tau post-translational modifications
Abstract Background Tau is a microtubule-binding protein, which is subject to various post-translational modifications (PTMs) including phosphorylation, methylation, acetylation, glycosylation, nitration, sumoylation and truncation. Aberrant PTMs such as hyperphosphorylation result in tau aggregatio...
Main Authors: | Ebru Ercan, Sameh Eid, Christian Weber, Alexandra Kowalski, Maria Bichmann, Annika Behrendt, Frank Matthes, Sybille Krauss, Peter Reinhardt, Simone Fulle, Dagmar E. Ehrnhoefer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-017-0229-1 |
Similar Items
-
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain
by: Ebru Ercan-Herbst, et al.
Published: (2019-12-01) -
Asparagine endopeptidase cleaves tau at N167 after uptake into microglia
by: Annika Behrendt, et al.
Published: (2019-10-01) -
SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s disease
by: Maria Bichmann, et al.
Published: (2021-07-01) -
Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
by: Anna Mietelska-Porowska, et al.
Published: (2014-03-01) -
Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
by: Sanjib Guha, et al.
Published: (2020-11-01)